Skip to main content
SpringerLink
Log in

D1 Immunotoxicology

  • Chapter
  • First Online:
Principles of Immunopharmacology

  • 1866 Accesses

Abstract

Pharmaceuticals for human use comprise a very wide variety of product types. These include traditional products (i.e., chemically synthesized or derived from NATURAL resources) as well as biological products (such as vaccines and blood products isolated from biological sources) and biotechnology-derived pharmaceuticals (such as peptide/protein products manufactured by RECOMBINANT DNA techniques, monoclonal antibodies and GENE THERAPY products).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Descotes JG, Vial T (1994) Cytoreductive drugs. In: JH Dean, MI Luster, AE Munson, I Kimber (eds): Immunotoxicology and Immunopharmacology, 2nd edn. Raven Press, New York, 293–301

    Google Scholar 

  2. Broide DH (1991) Inflammatory cells: structure and function. In: DP Stites, AI Terr (eds): Basic and Clinical Immunology. Prentice Hall International, London, 141–153

    Google Scholar 

  3. Ryffel B, Car BD, Eugster H-P, Woerly G (1994) Transplantation Agents. In: JH Dean, MI Luster, AE Munson, I Kimber (eds): Immunotoxicology and Immunopharmacology, 2nd edn. Raven Press, New York, 267–292

    Google Scholar 

  4. Majoor GD, Wodzig WH, Vriesman PJCVB (1991) Cyclosporin-induced autoimmunity. In: MD Kendall, MA Ritter (eds): Thymus Update: Thymus in Immunotoxicology. Harwood Academic Publishers, London, 179–200

    Google Scholar 

  5. Cohen JJ (1992) Glucocorticoid-induced Apoptosis in the Thymus. Seminars in Immunology. Academic Press, New York

    Google Scholar 

  6. Clark EA, Ledbetter JA (1994) How B- and T-cells talk to each other. Nature 367: 425–428

    Article  PubMed  CAS  Google Scholar 

  7. Matzinger P (1994) Tolerance, danger and the extended family. Annu Rev Immunol 12: 991–1045

    Article  PubMed  CAS  Google Scholar 

  8. Crommelin DJA, Storm G, Verrijk R, de Leede L, Jiskoot W, Hennink WE (2003) Shifting paradigms: Biopharmaceuticals versus low molecular weight drugs. Int J Pharmaceutics 266: 3–16

    Article  CAS  Google Scholar 

  9. Vial T, Descotes J (1995) Immune-mediated side effects of cytokines in humans. Toxicology 105: 31–57

    Article  PubMed  CAS  Google Scholar 

  10. Uetrecht J (1990) Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions. Crit Rev Toxicol 20: 213–235

    Article  PubMed  CAS  Google Scholar 

  11. Kubicka-Muranyi M, Kremer J, Rottmann N, Lübben B, Albers R, Bloksma N, Lührmann R, Gleichmann E (1996) Murine systemic autoimmune disease induced by mercuric chloride: T helper cells reacting to self proteins. Int Arch Allergy Immunol 109: 11–20

    Article  PubMed  CAS  Google Scholar 

  12. Pichler WJ (2003) Drug-induced autoimmunity. Curr Opin Allergy Clin Immunol 3: 249–253

    Article  PubMed  CAS  Google Scholar 

  13. Griem P, Panthel K, Kalbacher H, Gleichmann E (1996) Alteration of a model antigen by Au (III) leads to T-cell sensitization to cryptic peptides. Eur J Immunol 26: 279–287

    Article  PubMed  CAS  Google Scholar 

  14. Bloksma N, Kubicka-Muranyi M, Schuppe H-C, Gleichmann E, Gleichmann H (1995) Predictive immunotoxicological test systems: suitability of the popliteal lymph node assay in mice and rats. Crit Rev Toxicol 25: 369–396

    Article  PubMed  CAS  Google Scholar 

  15. Griem P, Gleichmann E (1995) Metal ion induced autoimmunity. Curr Opin Immunol 7: 831–838

    Article  PubMed  CAS  Google Scholar 

  16. Janeway CA (1992) The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 13: 11–16

    Article  PubMed  CAS  Google Scholar 

  17. Cohen IR (1992) The cognitive paradigm and the immunological homunculus. Immunol Today 13: 490–494

    Article  PubMed  CAS  Google Scholar 

  18. Ibrahim MAA, Chain BM, Katz DR (1995) The injured cell: the role of the dendritic cell system as a sentinel receptor pathway. Immunol Today 16: 181–186

    Article  PubMed  CAS  Google Scholar 

  19. Nierkens S, Van Helden P, Bol M, Bleumink R, Van Kooten P, Ramdien-Murli S, Boon L, Pieters R (2002) Selective requirement for CD40-d154 in drug-induced type 1 versus type 2 responses to trinitrophenyl-ovalbumin. J Immunol 168: 3747–3754

    PubMed  CAS  Google Scholar 

  20. Sgro C (1995) Side effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review. Toxicology 105: 23–29

    Article  PubMed  CAS  Google Scholar 

  21. Gleichmann E, Pals ST, Rolink AG, Radaszkiewicz T, Gleichmann H (1984) Graft-versus-host reactions: Clues to the etiopathology of a spectrum of immunological diseases. Immunol Today 5: 324–332

    Article  Google Scholar 

  22. Adams LE, Hess EV (1991) Drug-related lupus. Incidence, mechanisms and clinical implications. Drug Safety 6: 431–449

    Article  PubMed  CAS  Google Scholar 

  23. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N (2006) Cytokine in a phase I trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355: 1018–1028

    Article  PubMed  CAS  Google Scholar 

  24. Chatenoud L, Ferran C, Legendre C, Thouard I, Merote S, Reuter A, Gevaert Y, Kreis H, Franchimont P, Bach JF (1990) In vivo cell activation by OKT3 administration. Transplantation 49: 697–702

    Article  PubMed  CAS  Google Scholar 

  25. Moreau T, Coles A, Wing MG, Isaacs J, Hale G, Waldmann H, Compston A (1996) Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 119: 225–237

    Article  PubMed  Google Scholar 

  26. Stebbings R, Findlay L, Edwards C, Eastwood D, Bird C, North D, Mistry Y, Dilger P, Liefooghe E, Cludts I, Fox B, Tarrant G, Robinson J, Meager T, Dolman C, Thorpe SJ, Bristow A, Wadhwa M, Thorpe R, Poole S (2007) “Cytokine Storm”in the Phase I trial of Monoclonal antibody TGN1412: Better understanding the causes to improve preclinical testing of immunotherapeutics. J Immunol 179: 3325–3331

    PubMed  CAS  Google Scholar 

  27. Vidal JM, Kawabata TT, Thorpe R, Lima BS, Cederbrant K, Poole S, Mueller-Berghaus J, Pallardy M, Van der Laan JW (2010) European Medicines Agency-sponsored workshop: In vitro cytokine release assays for predicting cytokine release syndrome: The current state of the science. Cytokine 51: 213–215

    Article  PubMed  CAS  Google Scholar 

  28. Janeway CA, Travers P (1994) Immunobiology: The immune system in health and disease. Current Biology Oxford

    Google Scholar 

  29. Druet P, Pelletier L, Rossert J, Druet E, Hirsch F, Sapin C (1989) Autoimmune reactions induced by metals. In: ME Kammuller, N Bloksma, W Seinen (eds): Autoimmunity and Toxicology: Immune Disregulation Induced by Drugs and Chemicals. Elsevier, Amsterdam, 349–361

    Google Scholar 

  30. Van Vliet E, Uhrberg M, Stein C, Gleichmann E (1993) MHC control of IL-4-dependent enhancement of B-cell Ia expression and Ig class switching in mice treated with mercuric chloride. Int Arch Allergy Immunol 101: 392–401

    Article  PubMed  Google Scholar 

  31. Albers R (1996) Chemical-induced Autoimmunity –Immune Disregulation Assessed with Reporter Antigens. Utrecht University, PhD thesis

    Google Scholar 

  32. Jonulit H, Schmitt E (2003) The regulatory T cell family: Distinct subsets and their interrelations. J Immunol 171: 6323–6327

    Google Scholar 

  33. Layland LE, Wulferink M, Dierkes S, Gleichmann E (2004) Drug-induced autoantibidy formation in mice: Triggering by primed CD4+CD25– T cells, prevention by primed CD4+CD25+ T cells. Eur J Immunol 34: 36–46

    Article  PubMed  CAS  Google Scholar 

  34. Mason MJ, Uetrecht J (2004) Tolerance indiced by low dose d-penicillamine in the Brown Norway rat model of drug-induced autoimmunity is immune mediated. Chem Res Toxicol 17: 82–94

    Article  Google Scholar 

  35. Coleman JW, Sim E (1994) Autoallergic responses to drugs: mechanistic aspects. In: JH Dean, MI Luster, AE Munson, I Kimber (eds): Immunotoxicology and Immunopharmacology, 2nd edn. Raven Press, New York, 553–572

    Google Scholar 

  36. Descotes J, Choquet-Kastylevsky G (2001) Gell and Coombs’s classification: is it still valid? Toxicology 158: 43–49

    Article  PubMed  CAS  Google Scholar 

  37. Adkinson NF Jr, Essayan D, Gruchalla R, Haggerty H, Kawabata T, Sandler JD, Updyke L, Shear NH, Wierda D (2002) Task force report: Future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J Allergy Clin Immunol 109: S461–78

    Article  PubMed  Google Scholar 

  38. Uetrecht J (2009) Immune-mediated adverse drug reactions. Chem Res Toxicol 22: 24–34

    Article  PubMed  CAS  Google Scholar 

  39. IPCS (1996) International Programme for Chemical Safety, Environmental Health Criteria Document 160. Principles And Methods for Assessing Direct Immunotoxicity Associated with Chemical Exposure. Geneva: World Health Organization

    Google Scholar 

  40. Vos JG (1980) Immunotoxicity assessment: screening and function studies. Arch Toxicol Suppl 4: 95–108

    PubMed  CAS  Google Scholar 

  41. Van Loveren H, Vos JG (1989) Immunotoxicological considerations: a practical approach to immunotoxicity testing in the rat. In: Dayan AD, Paine AJ (eds): Advances in Applied Toxicology. Taylor and Francis, London, 143–165

    Google Scholar 

  42. Vos JG, Krajnc EI (1983) Immunotoxicity of pesticides. In: AW Hayes, RC Schnell, TS Miya (eds): Developments in the Science and Practice of Toxicology. Elsevier, Amsterdam, 229–240

    Google Scholar 

  43. De Waal EJ, Van Loveren H, Vos JG (1997) Practice of tiered testing for immunosuppression in rodents. Drug Information J 31: 1317–1323

    Google Scholar 

  44. Koeter HBWM (1995) International harmonisation of immunotoxicity testing. Hum Exp Toxicol 14: 151–154

    Article  PubMed  CAS  Google Scholar 

  45. Van Loveren H, Vos JG, De Waal EJ (1996) Testing immunotoxicity of chemicals as a guide for testing approaches for pharmaceuticals. Drug Information J 30: 275–279

    Google Scholar 

  46. Van Loveren H, Gianotten N, Hendriksen CFM, Schuurstorm man H-J, Van Der Laan JW (1994) Assessment of immunotoxicity of buprenorphine. Lab Animals 28: 355–363

    Article  Google Scholar 

  47. De Waal EJ, De Jong WH, Van Der Vliet H, Verlaan B, Van Loveren H (1996) An immunotoxicity screening study on salmeterol in rats. Int J Immunopharmacol 18: 523–528

    Article  PubMed  Google Scholar 

  48. Schulte A, Althoff J, Ewe S, Richter-Reichhelm HB (2002) Two immunotoxicity ring studies according to OECD TG 407-comparison of data on cyclosporin A and hexachlorobenzene. Regul Toxicol Pharmacol 36: 12–21

    Article  PubMed  CAS  Google Scholar 

  49. Ladics GS, Smith C, Heaps K, Ellioo GS, Slone TW, Loveless SE (1995) Possible incorporation of an immunotoxicological funtional assay for assessing humoral immunity for hazard identification purposes in rats on standard toxicology study. Toxicology 96: 225–238

    Article  PubMed  CAS  Google Scholar 

  50. Van Loveren H, Vos J, Putman E, Piersma A (2003) Immunotoxicological consequences of perinatal chemical exposures: a plea for inclusion of immune parameters in reproduction studies. Toxicology 185: 185–191

    Article  PubMed  Google Scholar 

  51. Luster MI, Munson AE, Thomas PT, Holsapple MP, Fenters JD, White KL, Lauer LD, Germolec DR, Rosenthal GJ, Dean JH (1988) Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program’s guidelines for immunotoxicity evaluation in mice. Fund Appl Toxicol 10: 2–19

    Article  CAS  Google Scholar 

  52. Luster MI, Portier C, Pait DG, Rosenthal GJ, Germolec DR, Corsini E, Blaylock BL, Pollock P, Kouchi Y, Craig W et al (1993) Risk assessment in immunotoxicology. II. Relationship between immune and host resistance tests. Fund Appl Toxicol 21: 71–82

    CAS  Google Scholar 

  53. Germolec DR, Nyska A, Kashon M, Kuper CF, Portier C, Kommineni C, Johnson KA, Luster MI (2004) Extended histopathology in immunotoxicity testing: interlaboratory validation studies. Toxicol Sci 78: 107–115

    Article  PubMed  CAS  Google Scholar 

  54. Germolec DR, Kashon M, Nyska A, Kuper CF, Portier C, Kommineni C, Johnson KA, Luster MI (2004) The accuracy of extended histopathology to detect immunotoxic chemicals. Toxicol Sci 82: 504–511

    Article  PubMed  CAS  Google Scholar 

  55. Bugelski PJ, Thiem PA, Solleveld HA, Morgan DG (1990) Effects of sensitization to dinitrochlorobenzene (DNCB) on clinical pathology parameters and mitogen-mediated blastogenesis in cynomolgus monkeys (Macaca fascicularis). Toxicol Pathol 18: 643–650

    PubMed  CAS  Google Scholar 

  56. Ahmed-Ansari A, Brodie AR, Fultz PN, Anderson DC, Sell KW, McClure HM (1989) Flow microfluorometric analysis of peripheral blood mononuclear cells from nonhumam primates: Correlation of phenotype with immune function. Am J Primatol 17: 107–131

    Article  Google Scholar 

  57. Penninks AH, van Mierlo G, de Zeeuw-Brouwer M, Schijf M, Otto M (2010) The minipig in immunotoxicity testing. Tox Sci Abstr SOT 2010, P1980

    Google Scholar 

  58. Van der Laan JW, Brightwell J, Joszef Ratky J, McAnulty P, Stark C, Steering Group Rethink Project, (2010) Value of the minipig in the development of pharmaceuticals, chemicals and other products. J Pharmacol Toxicol Methods 62: 184–195

    Article  Google Scholar 

  59. Bode G, Sims J, Clausen P, Luft J, Steerig Group Rethink Project (2010) The utility of the minipig as an animal model in regulatory toxicology. J Pharmacol Toxicol Methods 62: 196–220

    Article  Google Scholar 

  60. Barratt MD, Basketter DA, Chamberlain M, Admans GD, Langowski JJ (1994) An expert system rule base for identifying contact allergens. Toxicol In Vitro 8: 1053–1060

    Article  PubMed  CAS  Google Scholar 

  61. Dupuis G, Benezra C (1982) Contact Dermatitis to Simple Chemicals: A Molecular Approach. Marcel Dekker, New York

    Google Scholar 

  62. Maurer T (1996) Predictive testing for skin allergy. In: JG Vos, M Younes, E Smith (eds): Allergic Hypersensitivities Induced by Chemicals. Recommendations for Prevention. CRC Press, Boca Raton, 237–259

    Google Scholar 

  63. Garssen J, Vandebriel RJ, Kimber I, Van Loveren H (1996) Hypersensitivity reactions: definitions, basic mechanisms, and localizations. In: JG Vos, M Younes, E Smith (eds): Allergic Hypersensitivities Induced by Chemicals. Recommendations for Prevention. CRC Press, Boca Raton, 19–58

    Google Scholar 

  64. Kimber I, Dearman RJ (1996) Contact hypersensitivity: immunological mechanisms. In: I Kimber, T Maurer (eds): Toxicology of Contact Hypersensitivity. Taylor and Francis, London, 14–25

    Google Scholar 

  65. Kimber I, Mitchell JA, Griffin AC (1986) Development of a murine local lymph node assay for the determination of sensitizing potential. Food Chem Toxicol 24: 585–586

    Article  CAS  Google Scholar 

  66. Van Och FM, Slob W, de Jong WH, Vandebriel RJ, van Loveren H (2000) A quantitative method for assessing the sensitizing potency of low molecular weight chemicals using a local lymph node assay: employment of a regression method that includes determination of the uncertainty margins. Toxicology 20: 49–59

    Google Scholar 

  67. Dearman RJ, Mitchell JA, Basketter DA, Kimber I (1992) Differential ability of occupational chemical contact and respiratory allergens to cause immediate and delayed dermal hypersensitivity reactions in mice. Int Arch Allergy Appl Immunol 97: 315–321

    Article  CAS  Google Scholar 

  68. Garssen J, Nijkamp FP, Van Der Vliet H, Van Loveren H (1991) T-cell mediated induction of airway hyperreactivity in mice. Am Rev Respir Dis 144: 931–938

    PubMed  CAS  Google Scholar 

  69. Scheerens H, Buckley TL, Davidse EM, Garssen J, Nijkamp FP, Van Loveren H (1996) Toluene diisocyanate-induced in vitro tracheal hyperreactivity in the mouse. Am J Respir Crit Care Med 154: 858–865

    PubMed  CAS  Google Scholar 

  70. Van Och FM, Van Loveren H, De Jong WH, Vandebriel RJ (2002). Cytokine production induced by lowmolecular-weight chemicals as a function of the stimulation index in a modified local lymph node assay: An approach to discriminate contact sensitizers from respiratory sensitizers. Toxicol Appl Pharmacol 184: 46–56

    Article  PubMed  Google Scholar 

  71. Karol MH (1996) Predictive testing for respiratory allergy. In: JG Vos, M Younes, E Smith (eds): Allergic Hypersensitivities Induced by Chemicals. Recommendations for Prevention. CRC Press, Boca Raton, 125–137

    Google Scholar 

  72. Karol MH, Griffiths-Johnson DA, Skoner DP (1993) Chemically induced pulmonary hypersensitivity, airway hyperreactivity and asthma. In: D Gardner et al (eds): Toxicology of the Lung, 2nd edn. Raven Press, New York, 417–433

    Google Scholar 

  73. Sarlo K Clark ED (1992) A tier approach for evaluating the respiratory allergenicity of low molecular weight chemicals. Fund Appl Toxicol 85: 55–58

    Google Scholar 

  74. Hessel EM, Van Oosterhout AJM, Hofstra CL, De Bie JJ, Garssen J, Van Loveren H, Verheyen AKCP, Savelkoul HFJ, Nijkamp FP (1995) Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur J Pharmacol Env Tox Pharmacol Sect 293: 401–412

    Article  CAS  Google Scholar 

  75. Kammüller ME, Bloksma N, Seinen W (eds) (1989) Autoimmunity and Toxicology: Immune Dysregulation Induced by Drugs And Chemicals. Elsevier, Amsterdam

    Google Scholar 

  76. Pieters R, Nierkens S (2007) Experimental models of autoimmunity. In: R Luebke, R House, I Kimber (eds): Immunotoxicology and Immunopharmacology, 3rd edn, CRC press, Boca Raton, 469–485

    Google Scholar 

  77. Gleichmann E, Vohr HW, Stringer C, Nuyens J, Gleichmann H (1989) Testing the sensitization of T-cells to chemicals. From murine graft-versus-host (GVH) reactions to chemical-induced GVH-like immunological diseases. In: ME Kammüller, N Bloksma, W Seinen (eds): Autoimmunity and Toxicology: Immune Dysregulation Induced by Drugs And Chemicals. Elsevier, Amsterdam, 364–390

    Google Scholar 

  78. Gleichmann E, Kind P, Schuppe HC, Merk H (1990) Tests for predicting sensitization to chemicals and their metabolites, with special reference to heavy metals. In: AD Dayan, RF Hertel, E Heseltine, G Kazantzis, EM Smith, Van Der Venne MT (eds): Immunotoxicity of Metals and Immunotoxicology. Plenum Press, New York, 139–152

    Google Scholar 

  79. Pieters R, Albers R (1999) Screening tests for autoimmune-related immunotoxicity. Environ Health Persp (Suppl 5): 673–677

    Google Scholar 

  80. Weaver J, Chapdelaine J, Descotes J, Germolic D, Holsapple M, House R, Lebrec H, Meade J, Pieters R, Hastings K, Dean J (2005) Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with the potential to cause immune mediated drug reactions. J Immunotoxicol 2: 11–20

    Article  PubMed  CAS  Google Scholar 

  81. Vial T, Carleer J, Legrain B, Verdier F, Descotes J (1997) The popliteal lymph node assay: results of a preliminary interlaboratory validation study. Toxicology 122: 213–218

    Article  PubMed  CAS  Google Scholar 

  82. Albers R, Broeders A, ven der Pijl A, Seinen W, Pieters R (1997) The use of reporter antigensin the popliteal lymph node assay to assess immunomodulation by chemicals. Toxicol Appl Pharmacol 143: 102–109

    Article  PubMed  CAS  Google Scholar 

  83. Gutting BW, Updyke LW, Amacher DE (2002) BALB/c mice orally pretreated with diclofenac have augmented and accelerated PLNA responses to diclofenac. Toxicology 172: 217–230

    Article  PubMed  CAS  Google Scholar 

  84. Selgrade MJ, Cooper KD, Devlin RB, Van Loveren H, Biagini RE, Luster MI (1995) Immunotoxicity-Bridging the gap between animal research and human health effects. Fund Appl Toxicol 24: 13–21

    Article  CAS  Google Scholar 

  85. National Research Council (1992) Biological Markers in Immunotoxicology. National Academy Press, Washington

    Google Scholar 

  86. Levy SM, Herberman RB, Lee J, Whiteside T, Beadle M, Heiden L, Simons A (1991) Persistantly low natural killer activity, age, and environmental stress as predictors of infectious morbidity. Nat Immun Cell Growth Regul 10: 289–307

    PubMed  CAS  Google Scholar 

  87. Bentwich Z, Bianco N, Jager L, Houba V, Lambert PH, Knaap W, Rose N, Seligman M, Thompson R, Torrigiani G et al (1982) Use and abuse of laboratory tests in clinical immunology: Critical considerations of eight widely used diagnostic procedures. Report of a Joint IUIS/WHO Meeting on Assessment of Tests Used in Clinical Immunology. Clin Immunol Immunopathol 24: 122–138

    Google Scholar 

  88. Bentwich Z, Beverley PCL, Hammarstrom L, Kalden JR, Lambert PH, Rose NR, Thompson RA (1988) Laboratory investigations in clinical immunology: Methods, pitfalls, and clinical indications. Clin Immunol Immunopathol 49: 478–497

    Article  Google Scholar 

  89. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds) (1994) Current Protocols in Immunology, vol. 1 and 2. John Wiley and Sons, New York

    Google Scholar 

  90. Lawlor GJ, Fischer TJ (eds) (1988) Manual of Allergy and Immunology. Diagnosis and Therapy, 2nd edn. Little, Brown, Boston

    Google Scholar 

  91. Miller LE, Ludke HR, Peacock JE, Tomar RH (eds) (1991) Manual of Laboratory Immunology, 2nd edn. Lea and Fabiger, Philadelphia

    Google Scholar 

  92. Van Loveren H, Van Amsterdam JG, Vandebriel RJ, Kimman TG, Rumke HC, Steerenberg PS, Vos JG (2001) Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect 109: 757–764

    Article  PubMed  Google Scholar 

  93. Sleijffers A, Yucesoy B, Kashon M, Garssen J, De Gruijl FR, Boland GJ, Van Hattum J, Luster MI, Van Loveren H (2003) Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination. J Immunol 170: 3423–3428

    PubMed  CAS  Google Scholar 

  94. Diggle GE (1993) Overview of regulatory agencies. In: B Ballantyne, T Marrs, P Turner (eds): General and Applied Toxicology. MacMillan, Basingstoke, 1071–1090

    Google Scholar 

  95. Putman E, Van der Laan JW, Van Loveren H (2003) Assessing immunotoxicity: guidelines. Fund Clin Pharmacol 17: 615–626

    Article  CAS  Google Scholar 

  96. Weaver J, Tsutsui N, Hisada S, Vidal J-M, Spanhaak S, Sawada J-I, Hastings KL, Van der Laan JW, Van Loveren H, Kawabata TT, Sims J, Durham SK, Fueki O, Matula T, Kusunoki H, Ulrich P, Nakamura K (2005) Development of the ICH Guidelines on Immunotoxicology. Evaluation of pharmaceuticals using a survey of industry practices. J Immunotoxicol 2: 171–180

    CAS  Google Scholar 

  97. International Conference on Harmonization of technical requirements for pharmaceuticals for human use. (2006) Note for Guidance on immunotoxicity studies for human pharmaceuticals. www.ich.org, www.ema. europa.eu/human medicines

  98. Luster MI, Dean JH, Germolec DR (2003) Consensus workshop on methods to evaluate developmental immunotoxicity. Environ Health Perspect 111: 579–583

    Article  PubMed  CAS  Google Scholar 

  99. Mattes WB, Walker EG (2009) Translational toxicology and the work of the prodictive safety testing consortium. Clin Pharmacol Ther 85: 327–330

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunotoxicology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, 80177, 3508 TD, Utrecht, The Netherlands

    Raymond Pieters

  2. Section on Safety of Medicines and Teratology, Centre for Biological Medicines and Medical Technology, National Institute for Public Health and the Environment, 1, 3720 BA, Bilthoven, The Netherlands

    Jan Willem van der Laan

  3. Laboratory for Health Protection Research, National Institute of Public Health and the Environment, 1, 3720 BA, Bilthoven, The Netherlands

    Henk van Loveren

  4. Department of Toxicogenomics, Maastricht University, 616, 6200 MD, Maastricht, The Netherlands

    Henk van Loveren

Authors
  1. Raymond Pieters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph G. Vos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jan Willem van der Laan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Henk van Loveren
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raymond Pieters .

Editor information

Editors and Affiliations

  1. Faculteit Farmacie, Rijksuniversiteit Utrecht, Utrecht, Netherlands

    F.P. Nijkamp

  2. Diseases "Dr. Fran Mihaljevic", Research & Clinical Immunology Unit, University Hospital for Infectious, Mirogojska cesta 8, Zagreb, 10000, Croatia

    Michael J. Parnham

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Birkhäuser Basel

About this chapter

Cite this chapter

Pieters, R., Vos, J.G., van der Laan, J.W., van Loveren, H. (2011). D1 Immunotoxicology. In: Nijkamp, F., Parnham, M. (eds) Principles of Immunopharmacology. Birkhäuser Basel. https://doi.org/10.1007/978-3-0346-0136-8_31

Download citation

Publish with us

Policies and ethics

Search

Navigation